🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To explore the efficacy and safety of chidamide combined with endocrine in ...
Status
Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College
Start Date
2023-07-20
Trial ID
NCT05983107
Treatments Being Tested
To explore the efficacy and safety of Chidamide combined with endocrine for...
Status
Recruiting
Location
天津市肿瘤医院
Start Date
2023-05-16
Trial ID
NCT05890287
Treatments Being Tested
CDK4/6 inhibitors are currently the standard treatment for female breast ca...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2023-05-15
Trial ID
NCT05861830
This phase II study focuses on women with rapidly progressive hormone recep...
Status
Completed
Location
Jiangsu Provincial People's Hospital
Start Date
2024-01-09
Trial ID
NCT06375707
Treatments Being Tested
This study aims to enroll premenopausal patients, with early breast cancer ...
Status
Unknown
Location
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Start Date
2023-06-01
Trial ID
NCT05801705
This phase II, multicenter, open-label, randomized controlled trial (FACET ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-10-01
Trial ID
NCT07716046
Treatments Being Tested
This is an open-label, single-center, exploratory, Phase Ib/II clinical tri...
Status
Recruiting
Location
Tianjin Medical University Cancer Institute and Hospital
Start Date
2025-06-23
Trial ID
NCT07708194
Treatments Being Tested
To compare safety of adjuvant OFS combined with anastrozole versus OFS comb...
Status
Completed
Location
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
Start Date
2015-05
Trial ID
NCT02440230
Treatments Being Tested
To compare the efficacy and safety of ribociclib in combination with aromat...
Status
Recruiting
Location
Jiangsu Provincial People's Hospital
Start Date
2024-08-13
Trial ID
NCT06656624
This study is a multi-center prospective real-world clinical study, mainly ...
Status
Unknown
Location
Tianjin Cancer Hospital
Start Date
2022-01-23
Trial ID
NCT05167643
Treatments Being Tested